Organ-on-a-chip maker Emulate has launched an upgraded offering for researchers studying inflammatory bowel disease with its tissue model that helps illustrate how immune cells are activated and ...
Platform adopted by 10 of the top 25 biopharmaceutical companies, by U.S. governmental agencies, and by academic research centers worldwide Organs-on-Chips enable drug developers and researchers to ...
Emulate, Inc. today announced the company’s launch with a $12 million Series A financing to commercialize a first-in-kind, automated ‘Organs-on-Chips’ platform that mimics human physiology and ...
The human guinea pig may soon be extinct. He (it’s usually a ‘he’) has become endangered through the advances of cell culture science, which increasingly close the gap between in vitro testing (the ...
Scientists can now do research on live human organs without petri dishes or animal testing.
Emulate is the leading provider of next generation in vitro biological models. Researchers use their organ-on-a-chip technology to understand and predict drug response with greater precision and ...
Recent pre-clinical studies confirm predictable, specific and statistically significant effects in multiple biological models. BELLEVUE, WA / ACCESSWIRE / February 15, 2022 / EMulate Therapeutics, Inc ...
Research in space will use Emulate’s Organs-on-Chips technology to evaluate effects of space travel on human brain cells, and may help uncover new insights to understand neurological diseases on Earth ...
2021 was the most productive year in the company's history, setting up 2022 for major advances. BELLEVUE, WA / ACCESSWIRE / February 1, 2022 / EMulate Therapeutics, Inc., a clinical-stage therapeutic ...
This article was first published in the May 2016 issue of WIRED magazine. Be the first to read WIRED's articles in print before they're posted online, and get your hands on loads of additional content ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results